EP2729443
Bensýlamín afleiður sem plasma kallikrein hemlar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
6.7.2012EP published:
25.11.2015EP application number:
12735610.3
EP translation filed:
28.12.2015Grant published:
15.1.2016EPO information:
European Patent Register
Max expiry date:
5.7.2032Expiry date:
5.7.2023
Title:
BENZYLAMINE DERIVATIVES AS INHIBITORS OF PLASMA KALLIKREIN
Timeline
Today
6.7.2012EP application
25.11.2015EP Publication
28.12.2015Translation submitted
15.1.2016Registration published
5.7.2023Expires
Owner
Name:
Kalvista Pharmaceuticals LimitedAddress:
Building 227 Tetricus Science park, Salisbury, Wiltshire SP4 0JQ, GB
Inventor
Name:
EVANS, David MichaelAddress:
Salisbury SP4 0JQ, GB
Name:
DAVIE, Rebecca LouiseAddress:
Salisbury SP4 0JQ, GB
Name:
EDWARDS, Hannah JoyAddress:
Salisbury SP4 0JQ, GB
Name:
ROOKER, David PhilipAddress:
Salisbury SP4 0JQ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201111682Date:
7.7.2011Country:
GB
Number:
201161505305 PDate:
7.7.2011Country:
US
Classification
Categories:
C07C 237/22, C07C 311/06, C07K 5/06, C07C 311/19, C07D 207/16
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.6.2016
Expires: 5.7.2017
Payer: Árnason Faktor
Number: 6
Paid: 7.6.2017
Expires: 5.7.2018
Payer: Árnason Faktor
Number: 7
Paid: 7.6.2018
Expires: 5.7.2019
Payer: Árnason Faktor
Number: 8
Paid: 5.6.2019
Expires: 5.7.2020
Payer: Árnason Faktor
Number: 9
Paid: 12.6.2020
Expires: 5.7.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.6.2021
Expires: 5.7.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.6.2022
Expires: 5.7.2023
Payer: Árnason Faktor ehf.